Speck B, Cornu P, Nissen C, Gratwohl A, Sartorius J
Pathol Biol (Paris). 1979 Jun;27(6):353-5.
We are reporting our experience with 13 patients suffering from end stage acute leukemia that were prepared for allogeneic bone marrow transplantation by combined chemotherapy followed by high dose cyclophosphamide (Cy) and total body irradiation (TBI). Only one patient became a long term survivor. Of the evaluable 12 patients, 6 died of interstitial pneumonia, 4 of GvH and 1 of recurrent leukemia. We conclude that adding combined chemotherapy to the standard conditioning program with Cy and TBI probably increases the risk of developing fatal interstitial pneumonia without eliminating the risk of recurrent leukemia. We suggest that allogenic marrow grafts should be performed earlier in the course of refractory acute leukemias, because in patients with end stage disease its chances of being curative are small.
我们报告了13例终末期急性白血病患者的治疗经验,这些患者通过联合化疗,随后接受高剂量环磷酰胺(Cy)和全身照射(TBI),为异基因骨髓移植做准备。只有1例患者成为长期幸存者。在可评估的12例患者中,6例死于间质性肺炎,4例死于移植物抗宿主病(GvH),1例死于白血病复发。我们得出结论,在标准的Cy和TBI预处理方案中添加联合化疗可能会增加发生致命性间质性肺炎的风险,同时又不能消除白血病复发的风险。我们建议,在难治性急性白血病病程中应尽早进行异基因骨髓移植,因为对于终末期疾病患者,治愈的机会很小。